WELLS FARGO & COMPANY/MN - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34
-46.0%
39
-20.4%
0.00%
Q2 2023$63
-36.4%
49
+4.3%
0.00%
Q1 2023$99
+296.0%
47
+2.2%
0.00%
Q4 2022$2546
+2.2%
0.00%
Q3 2022$045
+25.0%
0.00%
Q2 2022$036
+9.1%
0.00%
Q1 2022$033
+3.1%
0.00%
Q4 2021$0320.0%0.00%
Q3 2021$0320.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$158,0000.15%
Nantahala Capital Management 686,756$1,415,0000.05%
Board of Trustees of The Leland Stanford Junior University 247,583$510,0000.03%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$32,0000.02%
Frontier Wealth Management LLC 18,800$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$53,0000.00%
MORGAN STANLEY 2$00.00%
BlackRock Inc. 16,045$33,0000.00%
VANGUARD GROUP INC 22,695$47,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders